Literature DB >> 28284977

Mesalamine desensitization in a patient with treatment refractory ulcerative colitis and aspirin and nonsteroidal anti-inflammatory drug hypersensitivity.

Jordan L Heath1, Ryan D Heath1, Cyrus Tamboli1, Larry Johnson1, Ashley S Wilson2, Sheva Chervinskiy3, Matthew C Bell4, Joshua L Kennedy5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28284977     DOI： 10.1016/j.anai.2017.01.026

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  3 in total

1.  5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis.

Authors:  Shinta Mizuno; Keiko Ono; Yohei Mikami; Makoto Naganuma; Tomohiro Fukuda; Kazuhiro Minami; Tatsuhiro Masaoka; Soichiro Terada; Takeshi Yoshida; Keiichiro Saigusa; Norimichi Hirahara; Hiroaki Miyata; Wataru Suda; Masahira Hattori; Takanori Kanai
Journal:  Intest Res       Date:  2020-01-30

2.  Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease.

Authors:  Satohiro Matsumoto; Hirosato Mashima
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

Review 3.  NSAID Hypersensitivity in the Pediatric Population: Classification and Diagnostic Strategies.

Authors:  Ozlem Cavkaytar; Mustafa Arga
Journal:  J Asthma Allergy       Date:  2022-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.